A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT06602219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Ranging Study of LY4100511 (DC-853) for the Treatment of Adult Participants With Moderate-to Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to assess the safety and efficacy of LY4100511 in adult participants with moderate-to-severe plaque psoriasis.
Study identification
- NCT ID
- NCT06602219
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 222 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 25, 2024 (Actual)
- Primary completion
- Jul 24, 2025 (Actual)
- Completion
- Sep 4, 2025 (Actual)
- Last update posted
- Aug 18, 2026
2024 – 2025
United States locations
- U.S. sites
- 15
- U.S. states
- 7
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology Skin Health Center | Birmingham | Alabama | 35244 | — |
| Dermatology Trial Associates | Bryant | Arkansas | 72022 | — |
| Zenith Research, Inc. | Beverly Hills | California | 90212 | — |
| First OC Dermatology Research Inc | Fountain Valley | California | 92708 | — |
| Center for Dermatology Clinical Research | Fremont | California | 94538-1614 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Driven Research | Coral Gables | Florida | 33134 | — |
| Direct Helpers Research Center | Hialeah | Florida | 33012 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| GCP Global Clinical Professionals, LLC | St. Petersburg | Florida | 33713-8012 | — |
| ForCare Clinical Research | Tampa | Florida | 33613 | — |
| Endeavor Clinical Trials Center - Dermatology - Skokie | Skokie | Illinois | 60077-1049 | — |
| Lawrence J Green, M.D, LLC | Rockville | Maryland | 20850 | — |
| Center for Clinical Studies, LTD.LLP | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06602219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06602219 live on ClinicalTrials.gov.